{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Universe Pharmaceuticals, Inc.
Is Universe Pharmaceuticals, Inc. technically bullish or bearish?
As of May 6, 2024, Universe Pharmaceuticals, Inc. has a mildly bullish technical trend supported by the weekly MACD and Dow Theory, despite bearish signals from daily moving averages and Bollinger Bands.
What does Universe Pharmaceuticals, Inc. do?
Universe Pharmaceuticals, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $19 million and a net loss of $77 million as of June 2012. The company has a market cap of $2.24 million and no dividend yield.
How big is Universe Pharmaceuticals, Inc.?
As of Jun 18, Universe Pharmaceuticals, Inc. has a market capitalization of 2.24 million and reported net sales of 162.49 million with a net profit loss of 315.54 million for the latest four quarters. The balance sheet as of Sep 24 shows shareholder's funds of 45.50 million and total assets of 67.95 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
